₹193.21
−4.18%NSE close, 16 Nov 2026
+113.11%
IOL Chemicals and Pharmaceuticals is a small cap company, listed on NSE under the symbol IOLCP. At ₹193.21 a share, the market values the whole company at ₹5,671 crore.
In FY26, it reported sales of ₹2,319 crore and a net profit of ₹138 crore, an operating margin of 11.6%. Over the last three years, sales grew 1.5% a year and net profit fell 0.4% a year.
The market values the company at 27.9 times its profit over the last twelve months and 2.95 times its book value; its return on equity is 10.6% and its borrowings are 0.10 times its equity.
Promoters hold 62.28% of the shares. Foreign institutions hold 7.25%, and domestic institutions, mutual funds among them, 0.30%.
Over the past year the share price has risen 113.3%, and it is 13.8% below its 52-week high.
₹ crore. Consolidated figures.
Significant increase in volume has been observed in IOL Chemicals and Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is…
Significant increase in volume has been observed in IOL Chemicals and Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is…
Transcript
Link of Recording
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 520 | 504 | 502 | 526 | 523 | 528 | 552 | 568 | 580 | 619 | 756 | 795 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 476 | 454 | 451 | 484 | 476 | 465 | 490 | 510 | 523 | 527 | 653 | 686 |
| Operating profit | 44.4 | 49.5 | 51.1 | 41.6 | 46.9 | 62.8 | 62.1 | 57.1 | 57.3 | 92.5 | 103 | 109 |
| Operating margin | 8.5% | 9.8% | 10.2% | 7.9% | 9.0% | 11.9% | 11.3% | 10.1% | 9.9% | 14.9% | 13.7% | 13.8% |
| Other income | 8.4 | 7.5 | 7.4 | 6.4 | 4.1 | 4.5 | 7.4 | 6.9 | 5.3 | 1.8 | 8.2 | 5.5 |
| Interest | 4.3 | 3.4 | 2.2 | 4.1 | 4.5 | 4.0 | 4.2 | 3.5 | 3.6 | 3.2 | 3.6 | 5.4 |
| Depreciation | 16.3 | 16.4 | 16.8 | 17.9 | 18.7 | 18.6 | 19.8 | 20.0 | 20.2 | 20.3 | 21.3 | 22.2 |
| Profit before tax | 32.1 | 37.2 | 39.5 | 25.9 | 27.8 | 44.7 | 45.5 | 40.5 | 27.6 | 70.8 | 86.7 | 87.3 |
| Tax | 9.0 | 9.6 | 9.6 | 6.8 | 7.3 | 13.3 | 11.6 | 10.5 | 7.0 | 17.7 | 22.3 | 22.2 |
| Net profit | 23.1 | 27.6 | 30.0 | 19.2 | 20.5 | 31.4 | 33.9 | 30.0 | 20.6 | 53.2 | 64.4 | 65.1 |
| EPS (₹) | 3.93 | 4.71 | 5.11 | 3.26 | 3.50 | 1.07 | 1.16 | 1.02 | 0.70 | 1.81 | 2.20 | 2.21 |
₹ crore, financial years to March.
| Line | FY19 S | FY20 S | FY21 S | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,685 | 1,894 | 1,967 | 2,184 | 2,217 | 2,133 | 2,079 | 2,319 |
| Expenses | 1,276 | 1,321 | 1,375 | 1,926 | 1,991 | 1,902 | 1,877 | 2,050 |
| Operating profit | 410 | 574 | 592 | 258 | 226 | 231 | 202 | 269 |
| Operating margin | 24.3% | 30.3% | 30.1% | 11.8% | 10.2% | 10.8% | 9.7% | 11.6% |
| Other income | 10.4 | 16.0 | 24.3 | 32.0 | 25.6 | 30.1 | 22.4 | 21.4 |
| Interest | 51.4 | 20.9 | 5.8 | 8.3 | 16.5 | 16.1 | 14.8 | 14.6 |
| Depreciation | 32.5 | 35.7 | 38.9 | 43.3 | 46.2 | 62.9 | 72.0 | 80.2 |
| Profit before tax | 336 | 533 | 571 | 225 | 189 | 182 | 138 | 184 |
| Tax | 99.5 | 172 | 127 | 57.2 | 49.5 | 47.2 | 36.9 | 46.7 |
| Net profit | 237 | 361 | 445 | 168 | 139 | 134 | 101 | 138 |
| EPS (₹) | 42.11 | 127.02 | 76.21 | 28.56 | 23.70 | 22.90 | 3.44 | 4.69 |
₹ crore, at each year's end and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | Sep 2026 |
|---|---|---|---|---|---|
| Shareholders’ equity | 1,508 | 1,612 | 1,688 | 1,799 | 1,926 |
| Borrowings | 79.6 | 32.8 | 117 | 132 | 194 |
| Total liabilities | 514 | 633 | 694 | 788 | 905 |
| Fixed assets | 751 | 922 | 1,158 | 1,165 | 1,171 |
| Investments | 17.4 | 0 | 17.4 | 17.4 | 17.4 |
| Cash and equivalents | 1.4 | 7.7 | 78.2 | 65.4 | 9.4 |
| Total assets | 2,022 | 2,244 | 2,382 | 2,587 | 2,831 |
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 93.1 | 179 | 214 | 8.3 |
| From investing | −120 | −154 | −198 | −117 |
| From financing | −1.6 | 46.0 | −29.0 | 52.4 |
| Spent on fixed assets | −153 | −214 | −173 | −141 |
| Free cash flow | −60.2 | −34.9 | 41.3 | −133 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | 14.0% | 19.1% | 22.6% | 7.7% | 6.3% | 6.3% | 4.9% | 5.9% |
| Operating margin | 24.3% | 30.3% | 30.1% | 11.8% | 10.2% | 10.8% | 9.7% | 11.6% |
| Return on equity | – | – | – | – | 9.2% | 8.3% | 6.0% | 7.7% |
| Return on capital employed | – | – | – | – | 12.9% | 12.0% | 8.5% | 10.3% |
| Return on assets | – | – | – | – | 6.9% | 6.0% | 4.2% | 5.3% |
| Debt to equity | – | – | – | – | 0.05 | 0.02 | 0.07 | 0.07 |
| Interest coverage | 7.50 | 26.50 | 99.00 | 28.10 | 12.50 | 12.30 | 10.30 | 13.70 |
| Debt to assets | – | – | – | – | 0.04 | 0.01 | 0.05 | 0.05 |
| Current ratio | – | – | – | – | 2.02 | 2.00 | 1.89 | 1.78 |
| Quick ratio | – | – | – | – | 1.30 | 1.24 | 1.30 | 1.24 |
| Cash ratio | – | – | – | – | 0.00 | 0.01 | 0.13 | 0.09 |
| Asset turnover | – | – | – | – | 1.10 | 0.95 | 0.87 | 0.90 |
| Fixed asset turnover | – | – | – | – | 2.95 | 2.31 | 1.79 | 1.99 |
| Inventory turnover | – | – | – | – | – | 3.30 | 3.90 | 4.00 |
| Receivables turnover | – | – | – | – | 4.40 | 4.50 | 4.00 | 3.80 |
| Gross margin | – | – | – | – | – | 34.5% | 33.1% | 35.9% |
| Cash from operations to profit | – | – | – | 55.0% | – | – | 177.0% | 156.0% |
| Effective tax rate | 29.6% | 32.2% | 22.2% | 25.4% | 26.2% | 26.0% | 26.7% | 25.3% |
Press Release Financial Results for the quarter and half year ended 30th September 2026
The financial results for the period ended September 30, 2026.
Schedule of meet
EU-REACH Registration for Triacetin
Schedule of meet
Dispatch of Reminder letter to shareholders to update KYC
Submission of Voting Results along with Scrutinizer s Report with regard to the 39th Annual General Meeting of the Company
Proceedings of Annual General Meeting held on September 02, 2026